---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-26-005195"
form_type: "8-K"
ticker: "COSM"
cik: "0001474167"
company_name: "Cosmos Health Inc."
filed_at: "2026-08-20T21:11:15+00:00"
generated_at: "2026-08-20T21:12:10.482569+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Cosmos Health posts record Q2 revenue $18.99M, up 29% YoY; adjusted gross profit +58%

## Summary
- Q2 2026 revenue $18.99M (+28.8% YoY); H1 revenue $36.91M (+29.7%); adjusted annualized run-rate exceeds $75M.
- Q2 adjusted gross profit $1.84M, up 58.4%; adjusted gross margin expanded 165bps to 9.54%; op-ex grew ~half revenue rate.
- Net loss widened to $6.09M in Q2 (vs $2.83M) on $2.65M non-cash fair-value charges; adjusted EBITDA improved to -$1.13M.
- Total liabilities cut 13.3% to $40.79M; stockholders' equity up 12.2% to $20.67M; liabilities-to-assets ratio improved 550bps.
- Repurchased 2.65M shares ($513K) in Q2; total 5.11M shares (~$1.11M) under new $5M buyback; LOI to acquire Doc Pharma.

## SEC filing metadata
- accession: 0001477932-26-005195
- form_type: 8-K
- ticker: COSM
- cik: 0001474167
- company_name: Cosmos Health Inc.
- filed_at: 2026-08-20T21:11:15+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1474167/000147793226005195/0001477932-26-005195-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1474167/000147793226005195/cosm_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-26-005195
- JSON: https://secwatch.observer/filing/0001477932-26-005195.json
- Plain text: https://secwatch.observer/filing/0001477932-26-005195.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.